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Cargo sorting to intraluminal vesicles (ILVs) of multi-
vesicular endosomes is required for lysosome-
related organelle (LRO) biogenesis. PMEL—a com-
ponent of melanocyte LROs (melanosomes)—is
sorted to ILVs in an ESCRT-independent manner,
where it is proteolytically processed and assembled
into functional amyloid fibrils during melanosome
maturation. Here we show that the tetraspanin
CD63 directly participates in ESCRT-independent
sorting of the PMEL luminal domain, but not of
traditional ESCRT-dependent cargoes, to ILVs. Inac-
tivating CD63 in cell culture or inmice impairs amyloi-
dogenesis and downstream melanosome morpho-
genesis. Whereas CD63 is required for normal
PMEL luminal domain sorting, the disposal of the re-
maining PMEL transmembrane fragment requires
functional ESCRTs but not CD63. In the absence of
CD63, the PMEL luminal domain follows this frag-
ment and is targeted for ESCRT-dependent degrada-
tion. Our data thus reveal a tight interplay regulated
by CD63 between two distinct endosomal ILV sorting
processes for a single cargo during LRO biogenesis.
INTRODUCTION
Sorting of integral membrane protein cargoes to the intraluminal
vesicles (ILVs) of multivesicular endosomes (MVEs) is a key step
in many physiological processes including cessation of growth
factor signaling, lysosomal degradation, exosome secretion,
lysosome related organelle (LRO) biogenesis, and perhaps
even amyloid formation (Raiborg and Stenmark, 2009; Raposo
et al., 2007; Simons and Raposo, 2009; van Niel et al., 2006).
Lysosomal degradation generally requires the recognition of
ubiquitinated protein cargoes by components of the endosomal
sorting complex required for transport (ESCRT) machinery708 Developmental Cell 21, 708–721, October 18, 2011 ª2011 Elsev(Gruenberg and Stenmark, 2004; Hurley, 2008), in which the
ESCRT-0, -I and -II complexes recognize and sequester ubiqui-
tinated proteins in the endosomal membrane and the ESCRT-III
complex effects membrane budding and scission. However,
sorting of some proteins within MVEs, including physiologically
critical cargoes of exosomes and LRO biogenesis intermediates,
occurs independently of ubiquitination or ESCRT components
(Buschow et al., 2009; Simons and Raposo, 2009; Theos et al.,
2006b; Trajkovic et al., 2008). The mechanisms underlying
ESCRT-independent ILV sorting and their temporal and spatial
relationship with ESCRT-dependent sorting processes remain
poorly understood.
ESCRT-independent ILV sorting is important to generate
precursors for melanosomes. Melanosomes are LROs of mela-
nocytes and other pigment cells that are specialized for melanin
pigment synthesis. Melanosomes coexist with lysosomes and
form through four morphologically distinct stages (Seiji et al.,
1963), the earliest of which (stage I and II premelanosomes)
lack pigment but harbor fibrils that assemble into fibrillar sheets
uponwhich newly synthesizedmelanins polymerize duringmela-
nosome maturation. The fibrils underlie the elongated shape of
melanosomes and are composed largely of proteolytic lumenal
fragments of the amyloidogenic pigment cell-specific type I inte-
gral membrane protein, PMEL. The fibrils, which are thought to
concentrate melanins and to prevent the accumulation of toxic
intermediates generated during pigment synthesis (reviewed in
(Raposo et al., 2007; Theos et al., 2005; Watt et al., 2009),
form in association with the ILVs of stage I premelanosomes
(Hurbain et al., 2008) upon which PMEL accumulates (Raposo
et al., 2001). Stage I premelanosomes are vacuolarMVE interme-
diates that are accessed by endocytic tracers after 15 min,
contain few (n = 2–6) ILV profiles, and harbor abundant cla-
thrin-containing bilayered coats at their limiting membrane (Ra-
poso et al., 2001) that are enriched in the ESCRT-0 component
Hrs (Theos et al., 2006b). Paradoxically, PMEL is sorted to ILVs
by an ESCRT-independent mechanism (Theos et al., 2006b; Tru-
schel et al., 2009). The molecular basis for this sorting event is
not known, but it requires a lumenal subdomain of PMEL and
does not require any cytoplasmic domain determinant or ubiq-
uitination (Theos et al., 2006b). Sorting to ILVs correlates withier Inc.
Figure 1. CD63 Colocalizes with PMEL on ILVs of MVEs from Human Melanocytic Cells
(A) MNT-1 cells were analyzed by IFM after labeling for CD63 and for PMEL using antibody HMB50 (detects the luminal domain). Individual labels, a merged
image, and a 3-fold magnification of the merged image are shown. Note that labeling for CD63 and PMEL luminal domain partially overlap. Scale bar represents
10 mm.
(B–D) MNT-1 cells were processed for ultrathin cryosectioning and double immunogold labeled for PMEL luminal domain (HMB50; PAG 15) and CD63 (PAG 10).
(B) PMEL andCD63 are both present inMVEs (annotatedMVE on themicrograph) whereas only CD63 is observed onmaturingmelanosomes (annotated IV on the
micrograph). Scale bar represents 200 nm.
(C) Quantification of immunogold labeling for PMEL (using HMB50 antibody) and CD63. An equivalent number of gold particles representing labeling for PMEL
and for CD63 in the EManalysis was counted and assigned to the indicated compartments, whichwere identified bymorphology. Data are presented as themean
percentage of total gold particles in each compartment ± standard deviation (SD).
(D) Quantification of immunogold labeling on ILVs versus the limitingmembrane on coatedMVEs. Results are expressed as themean percentage of gold particles
(±SD) on ILVs (see B for an example) relative to total gold particles counted in MVEs.
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domain from the transmembrane form of PMEL to initiate
amyloid formation (Berson et al., 2001, 2003; Fowler et al.,
2006; Kummer et al., 2009). These processing events also
generate transmembrane fragments of PMEL that are destined
for g-secretase-dependent degradation by as yet incompletely
defined mechanisms (Kummer et al., 2009).
In other cell systems, ESCRT-independent formation of ILVs in
MVEs requires lipid rafts and ceramide (de Gassart et al., 2003;
Trajkovic et al., 2008) and/or protein aggregation (Fang et al.,
2007; Vidal et al., 1997). Other proposed regulators of ILV forma-
tion are proteins of the tetraspanin family (TSPAN) (Charrin et al.,
2009), which are selectively enriched in the ILVs of MVEs and in
exosomes derived from them (Simons and Raposo, 2009; van
Niel et al., 2006). Among TSPAN, CD63 is particularly enriched
intracellularly; in most cells it localizes predominantly to late
endosomes and lysosomes (Pols and Klumperman, 2009),
whereas in specialized cells CD63 is also present in LROs such
as endothelial cell Weibel-Palade bodies, platelet dense gran-
ules, and neutrophil myeloperoxidase granules (Pols and Klum-Developmperman, 2009; Raposo and Marks, 2007). Here, we investigated
the role of CD63 in PMEL sorting to ILVs and its ability to
generate amyloid fibrils in vitro and in vivo. We show that
CD63 functions in ESCRT-independent ILV formation, and that
it thereby modulates the fate of two distinct domains of PMEL
that are destined for amyloidogenesis and degradation. Impor-
tantly our data reveal a tightly regulated interplay between
ESCRT-independent and dependent sorting of distinct func-
tional domains of the same proteolytically cleaved cargo protein
to regulate organelle biogenesis.
RESULTS
CD63 Localizes to Melanosomes and to PMEL-Positive
MVEs
We first tested whether CD63 localizes to melanosomal com-
partments in pigmented MNT-1 melanoma cells, a faithful model
for eumelanogenesis (Raposo et al., 2001). Immunofluorescence
microscopy (IFM) analysis revealed that CD63 (Figure 1A), but
not the related tetraspanin CD81 (see Figure S1A availableental Cell 21, 708–721, October 18, 2011 ª2011 Elsevier Inc. 709
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partial colocalization with PMEL labeled by antibody HMB50. By
immunoelectron microscopy (IEM) using immunogold labeling
on ultrathin cryosections, CD63 localizes broadly to multiple
intracellular compartments, including predominantly mature
melanosomes (stages I–IV; Figure 1B, left, and Figure 1C), but
only 5%–10% localized to lysosomes (Figure 1C) as supported
by the low degree of overlap with LAMP-1 by IFM (Figure S1B).
Consistent with the degree of overlap by IFM, quantification of
the immunogold labeling shows that 20%–25% of CD63 is
detected on PMEL-positive MVEs (Figures 1B and 1C). Within
MVEs, more than 75% of the labeling for both CD63 and PMEL
is detected on ILVs rather than the limiting membrane (Figures
1B and 1D). This indicates that CD63, like PMEL, is preferentially
sorted to ILVs within melanocyte MVEs.
Our previous studies revealed that PMEL sorting to ILVs does
not require ubiquitination or functional ESCRT components
(Theos et al., 2006b; Truschel et al., 2009). Consistently, both
CD63 and PMELwere detected inMVEs in ultrathin cryosections
of MNT-1 cells in which the ESCRT-I subunit, Tsg101, was
depleted by siRNA treatment (Figures S1C and S1D). These
observations agree with previous findings that CD63-positive
MVEs continue to form despite concomitant inactivation of
subunits from four different ESCRT complexes (Stuffers et al.,
2009), and suggest that both CD63 and PMEL undergo
ESCRT-independent sorting into the ILVs of MVEs. The only
reported ‘‘effector’’ of ESCRT-independent ILV sorting is ceram-
ide in sorting the proteolipid PLP (Trajkovic et al., 2008). We
could not obtain evidence for a ceramide requirement in PMEL
and CD63 localization or amyloid formation using sphingomyeli-
nase inhibitors or siRNA-mediated inactivation of acidic type II
sphingomyelinase (Figures S1E and S1F).
CD63 Is Required for Intraluminal Vesicle Formation
and PMEL Distribution
We next explored the potential requirement for CD63 in ESCRT-
independent sorting of PMEL in MVEs by analyzing MNT-1 cells
in which CD63 was depleted by siRNA treatment. By western
blot analysis, treatment with either of two CD63-specific
siRNAs decreased the expression of CD63 by more than 80%
(Figure 2A). As in untreated cells, (Hurbain et al., 2008; Raposo
et al., 2001), MNT-1 cells treated with control siRNA and
analyzed by conventional electron microscopy (EM) harbor-
coated MVEs containing an average of 5 ILV profiles (Figure 2B,
left, and Figure 2D). By IEM, the ILVs are enriched in PMEL (Fig-
ure 2C, left, and Figure 2E). In CD63-inactivated cells, whereas
vacuolar endosomes with characteristic bilayered coats (Fig-
ure 2B, arrows) are unusually abundant (see Figures 3D and
3F), they are largely depleted of ILVs, with an average of less
than 2 ILV profiles per endosome (Figure 2B, right, and Fig-
ure 2D). Concomitantly, whereas labeling for PMEL was still de-
tected in coated endosomes in CD63-inactivated cells, it was
mostly localized to the limiting membrane (Figure 2C, right), re-
sulting in more than a 2-fold reduction in the fraction of PMEL
present on ILVs (Figure 2E). On those ILVs that were detectable
in CD63-depleted cells, the level of labeling for PMELwas similar
to that observed on ILVs in control cells (Figure 2F) suggesting
that the main effect of CD63 depletion was on ILV formation at
the coated endosome rather than on Pmel17 sorting to the ILVs.710 Developmental Cell 21, 708–721, October 18, 2011 ª2011 ElsevCD63 Is Required for the Generation of PMEL-Driven
Fibrils and Premelanosomes In Vitro and In Vivo
PMEL amyloid fibrils have been proposed to nucleate on ILVs in
the MVE lumen (Berson et al., 2001; Hurbain et al., 2008; Theos
et al., 2006b). We therefore evaluated the requirement for CD63
in the formation of PMEL amyloid fibrils. The antibody HMB45
detects an epitope on Golgi-modified PMEL that is most en-
riched on proteolytic fragments that accumulate on fibrils
(Harper et al., 2008; Hoashi et al., 2006; Kushimoto et al.,
2001). Inactivation of CD63, but not of CD81 (Figures S2A and
S2B), resulted in a consistent and specific reduction (93% ±
7% compared to control) in HMB45 labeling by both immuno-
blotting of fibril-enriched detergent-insoluble cell fractions (Fig-
ure 3A) and by IFM (Figure 3B). Nevertheless, CD63-depleted
MNT-1 cells retained punctate labeling by IFM for PMEL using
antibody HMB50, which recognizes awider panel of PMEL forms
(Harper et al., 2008) (Figure 3C). These data suggest that CD63 is
not required for PMEL expression or trafficking to post-Golgi
structures but is required for downstream fibril formation.
To further investigate the requirement for CD63 in melanogen-
esis, we analyzed the morphology of melanosomal compart-
ments in CD63-inactivated cells by EM. MNT-1 cells treated
with control siRNA display numerous stage II premelanosomes
harboring organized fibrils (Figure 3D, left, arrowheads, and Fig-
ure 3E1). CD63 depletion is accompanied by a dramatic and
quantitative reduction in the number of stage II premelanosomes
containing fully formed amyloid sheets (Figure 3D, right, and Fig-
ure 3F). As a potential consequence of inhibiting fibrillogenesis
after 3 days of CD63 depletion, the number of stage III pig-
mented melanosomes also decreased, while pigmented round
melanosomal structures with unstructured melanin deposits
accumulated (Figure 3D, right, arrowheads, and Figure 3F).
Consistent with this accumulation and with the lack of effect of
reduced PMEL expression on melanogenesis (Theos et al.,
2006a), melanin content slightly increased and melanin synthe-
sizing enzymes localized appropriately to the aberrant melano-
somes in CD63-depleted cells (Figures S2C andS2D).Moreover,
relative to controls, CD63-depleted cells harbored 4-fold the
number of compartments with lysosomal morphology (round
compartments of 500 nm diameter containing few internal vesi-
cles, dense material and lamellar structures) and additional
unique organelles with clearly visible dense aggregates (Figures
3E2 and 3E3), similar to those observed in cells with impaired
fibril formation due to a loss of PMEL processing (Berson et al.,
2003). This suggested that as a consequence of impaired
delivery of PMEL to ILVs of coated MVES in the absence of
CD63, amyloidogenesis and consequent melanosome matura-
tion are disrupted.
To investigate whether CD63 depletion affects melanogenesis
in a physiological setting, we analyzed pigment cells in CD63/
mice (Schro¨der et al., 2009). Compared to CD63+/+ mice,
CD63/ mice display variable graying of coat color (data not
shown). Because of potential compensatory effects observed
in skin melanocytes of mice with melanogenesis defects (Lopes
et al., 2007), we analyzed melanosome morphology in retinal
pigment epithelium (RPE) in which the compensatory effect is
less apparent. By EM, RPE of CD63/ mice have a dramatic
reduction in melanosome number (Figure 3G). Compared to
the characteristic ellipsoidal shaped melanosomes in the RPEier Inc.
Figure 2. Depletion of CD63 Inhibits Sorting of PMEL onto ILVs
(A) Western blot analysis of lysates of MNT-1 cells treated with control or two different CD63 siRNA using anti-CD63 antibody and anti-b-tubulin antibody as
a loading control.
(B) MNT-1 cells treated with control or CD63 siRNA #1 were analyzed by conventional EM. Black arrows indicate the ILVs; white arrows indicate the cytosolic
bilayered coats. Scale bar represents 200 nm.
(C) Ultrathin cryosections of MNT-1 cells treated with control (left) or CD63#1 siRNA (right) were immunogold labeled for PMEL luminal domain with HMB50 and
PAG10. Examples of MVEs from each sample are shown.Whereas in control cells labeling for PMEL luminal domain is associatedwith the ILVs, in CD63 depleted
cells the labeling is observed at the limiting membrane of the endosome close or within the clathrin coat (arrows). Scale bar represents 200 nm.
(D) The average number of ILVs (±SD) per coated MVE in 50 conventional EM profiles of each sample was quantified. *p < 0.05.
(E) Quantification of immunogold labeling for PMELwith HMB50 on ILVs of 100MVEs is expressed as themean percentage of gold particles (±SD) on ILVs relative
to total gold particles in MVEs. *p < 0.05.
(F) Same as (E) but results are expressed as the mean number of gold particles (±SD) per ILV within MVEs.
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melanosomes in CD63/ RPE are round (Figure 3G, bottom).
The round shape is consistent with a defect in the formation of
the structural scaffold formed by PMEL-derived amyloid
fibers in PMEL mutant silver mice (Theos et al., 2006a). These
observations indicate that amyloidogenesis and consequent
melanosome maturation are impaired in the absence of CD63
in vivo.
CD63 Is Required for Amyloidogenic Processing
of PMEL
PMEL sorting to ILVs correlates with proteolytic processing
steps that are required for PMEL to transition to the amyloid
form (Berson et al., 2003; Theos et al., 2006b). These steps
include: (1) cleavage of full-length PMEL by a prohormone con-
vertase into an amyloidogenic lumenal Ma fragment and a disul-
fide-linked transmembrane domain-containing Mb fragmentDevelopm(Berson et al., 2001); (2) further processing of Mb by a site 2
protease (S2P) to release Ma from the membrane and to
produce a C-terminal fragment (CTF) that is degraded by g-sec-
retase (Kummer et al., 2009); and (3) further processing of Ma
by unknown proteases to smaller fragments found in mature
fibers (Kushimoto et al., 2001; Watt et al., 2009) (Figure 4A).
To test whether CD63 depletion affects PMEL processing, we
assayed siRNA-treated MNT-1 cells by western blotting using
an antibody to the PMEL cytosolic domain (aPmel-C). In control
cells, this antibody detects the immature core-glycosylated
PMEL P1 form (90 kDa), the Mb (28 kDa) product of PC
cleavage, and CTF (10 kD) (Figures 4A and 4B). In CD63-
depleted cells (Figure 2A), Mb and CTF bands are detectable
but modestly decreased in intensity (Figure 4B). To distinguish
whether this reflects decreased production or accelerated
degradation of Mb and CTF, we blocked degradation of CTF
(but of not Mb or P1) by treating cells with the g-secretaseental Cell 21, 708–721, October 18, 2011 ª2011 Elsevier Inc. 711
Figure 3. Depletion of CD63 Inhibits Formation of PMEL Fibrils In Vitro and In Vivo
(A) Triton X-100-insoluble fraction fromMNT-1 cells treated with control or two different CD63 siRNA (CD63#1 and CD63#2) were analyzed by western blot using
HMB45 or b-tubulin antibody as a loading control. The percentage of signal intensity relative to the control is noted below each band.
(B and C) MNT-1 cells treated with the CD63#1 siRNA were analyzed by IFM after labeling for CD63 and HMB45 (B) or HMB50 (C). CD63-inactivated cells are
indicated by white stars; the micrographs were chosen to better emphasize the differences between CD63-inactivated cells and CD63-expressing cells. Scale
bar represents 10 mm.
(D) MNT-1 cells treated with control or CD63#1 siRNAwere analyzed by conventional EM. Arrows, bilayered coats onMVEs; arrowheads, maturingmelanosomes
(stage II and III). Scale bar represents 200 nm.
(E) Representative images of (1) stage II pre-melanosomes in control cells, and (2) dense unstructured aggregates or (3) lysosomes in CD63-depleted cells. Scale
bar represents 200 nm.
(F) Quantification of the number of different endosomal/melanosomal compartments, as indicated on the x axis and defined by morphology, observed by
conventional EM in MNT-1 cells treated with control and CD63 siRNA. Values represent the percentage of each compartment (±SD) relative to all of the
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CD63-depleted cells with DAPT induced a similar level of accu-
mulated CTF (Figure 4C). This suggested CD63 depletion accel-
erates CTF degradation but does not affect upstream PMEL
cleavages.
To further dissect how CD63 depletion affects PMEL process-
ing and fibril maturation, we probed immunoblots of cell fractions
with antibodies to additional PMEL epitopes. Ma fragments that
are released from the membrane anchor by PC and S2P
cleavage assemble into Triton X-100 insoluble fibrils (Berson
et al., 2003), detected by antibody aPmel-N to the PMEL
N-terminus, and then matured by further processing to smaller
digestion products detected by antibodies HMB45 and I51
(Harper et al., 2008; Hoashi et al., 2006; Watt et al., 2009).
In TX-100-insoluble fractions of CD63 siRNA-treated cells,
aPmel-N reactive Ma (but not aPmel-C-reactive cytoplasmic
fragments of PMEL) accumulated at normal or higher levels rela-
tive to control cells (Figures 4D and 4E), but smaller HMB45- and
I51-reactive fragments were depleted (Figures 3A and 4F). These
data confirm that CD63 is not required for PC and S2P process-
ing and release of the PMEL fibrillogenic lumenal domain, but
indicate that CD63 is required either for further processing
subsequent to ILV sorting or for stabilization of the resultant
fragments.
CD63 Interacts with the PMEL CTF
To test whether CD63 might influence PMEL ILV partitioning
and processing directly, we assayed for physical interactions
between CD63 and PMEL. To this end we first expressed
PMEL in HeLa cells by transfection and used coimmunoprecipi-
tation from cell lysates prepared in mild detergent (Brij 97) to
preserve tetraspanin-partner interactions. At steady state,
PMEL CTF was coimmunoprecipitated with anti-CD63 but not
with anti-CD81 (Figure 5A, upper right; note the signal above
the background bands, detected in untransfected HeLa cells,
upper left). Similar coimmunoprecipitation assays with endoge-
nous PMEL in MNT-1 cells failed to detect an interaction (data
not shown). However, consistent with the shorter half-life of
PMEL and its CTF in melanocytic cells compared with trans-
fected HeLa cells (Berson et al., 2001), CTF was coimmunopre-
cipitated with CD63—but not with the related tetraspanins CD81
or CD9—after treatment of MNT-1 cells with DAPT (Figure 5B,
top panels). Conversely, CD63 but not CD81 could be coimmu-
noprecipitated with aPmel-C from DAPT-treated MNT-1 cell
lysates (Figure 5B, bottom panels). MART-1, a known partner
of PMEL (Hoashi et al., 2005), also interacted with both PMEL
CTF and CD63 (Figure 5B), but was not necessary for the inter-
action between PMEL and CD63 as indicated by coimmunopre-
cipitation assays from HeLa cells that lack MART-1 (Figure 5A).
Together, these data indicate that CD63 interacts with the
CTF, likely reflecting a transient CTF-dependent interaction
with PMEL prior to cleavage by S2P.endosomal/melanosomal compartments identified in 50 cell profiles per condition
their lumen, whereas ‘‘coated MVEs’’ refers only to early endosomes/stage I me
vesicles within their lumen.
(G) Eyes sections from CD63+/+ (top) and CD63/ mice (bottom) were analyzed
segments (OS). Note the ellipsoidal melanosomes in RPE of CD63+/+ mice, and th
bars are indicated on each micrograph.
DevelopmThe C-Terminal Fragment of PMEL Is Degraded
in an ESCRT-I-Dependent Manner
Unlike the PMEL-lumenal domain that is clearly associated with
ILVs of stage I melanosomes (e.g., Figure 2C), the cytoplasmic
domain is mainly detected on the limiting membrane at steady
state (Berson et al., 2003; Raposo et al., 2001), suggesting
a distinct fate for the CTF after release from the lumenal domain.
Given that aPmel-C labeling is localized within clathrin and
Hrs-positive regions (Raposo et al., 2001; Theos et al., 2006b)
and that accelerated degradation (Figure 4B) in absence of
CD63 is correlated to an increased number of lysosomal struc-
tures (Figure 3F), we tested whether CTF disposal requires
ESCRT-dependent endosomal sorting by following the fate of
the CTF in MNT-1 cells depleted for Tsg101 (Figure 6A). Like
the ubiquitinated substrate MART-1 (Truschel et al., 2009), the
CTF, but not other PMEL isoforms, accumulated in lysates
from Tsg101-depleted cells relative to controls (Figure 6A). By
IFM, labeling for the Pmel C terminus in control cells yields
largely diffuse tubular or small punctate labeling representing
the ER, and perinuclear labeling representing largely the Golgi
(Figure 6B, upper panels, and Figure 6E, left panels; see also
Harper et al., 2008). By contrast, labeling for CTF in Tsg101-
depleted cells was detected in enlarged vacuoles that sur-
rounded structures labeled for the luminal domain of PMEL (Fig-
ure 6B, lower panels). IEM analysis revealed that the PMEL
lumenal domain was largely associated with small ILVs whereas
the PMEL cytoplasmic domain accumulated mostly at the
limiting membrane (Figures 6C and 6D). These observations
suggest that although sorting of the PMEL luminal domain
occurs in an ESCRT-independent manner, the CTF degradation
requires ESCRT-I function and is initiated from MVEs.
To infer the intracellular site of CTF degradation in MNT-1
cells, we allowed CTF to accumulate by inhibiting g-secretase
with DAPT. By IFM analysis, the largely tubulovesicular ER
labeling for the PMEL C terminus observed in control cells was
replaced in DAPT-treated cells by vesicular structures that re-
mained distinct from those harboring the PMEL luminal domain
(Figure 6C, right panels). Most of these structures colocalized
with LAMP1 in DAPT-treated control cells (and to some extent
in DAPT-treated CD63-depleted cells; Figure S4A), and IEM
analysis of these cells revealed an accumulation of the PMEL
cytoplasmic domain in small vesicles, conventional MVEs and
lysosomes that were distinct from stage II premelanosomes
(labeled for the PMEL luminal domain; Figure 6F). These obser-
vations suggest that if not degraded, the CTF accumulates in
lysosomes. Consistent with this conclusion, CTF also accumu-
lated in cells treated with lysosomal protease inhibitors (Fig-
ure S4B). Targeting to lysosomes required ESCRT-I, because
in Tsg101-depleted cells the CTF accumulated in endosomal
structures together with the luminal domain (Figures 6B–6D)
and did not localize to LAMP1-positive compartments (Fig-
ure S4A). These data indicate that the CTF is degraded within. Note that ‘‘total MVEs’’ refers to all compartments with internal vesicles within
lanosomes with a coat on the cytosolic side whatever the number of internal
by conventional EM. Shown are regions of the RPE and photoreceptor outer
e electron dense rounder structures (arrows) in the RPE of CD63/mice. Scale
ental Cell 21, 708–721, October 18, 2011 ª2011 Elsevier Inc. 713
Figure 4. Depletion of CD63 Affects the Processing of PMEL
(A) Schematic representation of PMEL maturation and the epitopes recognized by the antibodies used in this study. The maturation process is described in the
text. Black triangles, mature N- and O-linked glycosylation; black bar, a disulfide bond that links Ma and Mb; PC, proprotein convertase; ?, unknown proteases
that cleaveMa toMaC; ICD, intracellular domain of CTF. The names of the anti-PMEL antibodies used in this study and the isoforms they recognize are indicated.
(B)Whole cell lysates ofMNT-1 cells treatedwith control or CD63 siRNA #1 or #2were analyzed bywestern blot using aPmel-C antibody. The percentage of signal
intensity relative to the control is noted above each band.
(C) Whole cell lysates of MNT-1 cells treated with control or CD63 siRNA#1 and with 1 mMDAPT for 4 hr were analyzed by western blot using aPmel-C antibody.
(D–F) Triton X-100-soluble (Tx sol) and -insoluble (Tx insol) lysates of MNT-1 cells treated with control or CD63 siRNA#1 were analyzed by western blot using
aPmel-C (D), aPmel-N (E), or I51 antibody (F).
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ing to this pathway.
Endosomal bilayered clathrin- and Hrs-containing coats func-
tion in other cell types in ESCRT-dependent sorting of ubiquiti-
nated substrates to ILVs of MVBs for lysosomal degradation
(Raiborg et al., 2006, 2008; Raposo et al., 2001; Sachse et al.,
2002; Theos et al., 2006b). Consistent with such a fate for the
CTF, EM of DAPT-treated cells indicates an expansion of bilay-714 Developmental Cell 21, 708–721, October 18, 2011 ª2011 Elsevered clathrin coats on the cytosolic face of MVEs (Figure 6G).
IEM revealed that the labeling for the CTF was highly enriched
in these coated regions (Figure 6H). Because Hrs binds avidly
to ubiquitinated cytosolic domains of transmembrane proteins,
we tested whether the CTF was associated with ubiquitylation
by immunoprecipitating CTF and other PMEL isoforms from
control and DAPT-treated cell lysates and assaying for ubiquitin
by immunoblotting. Relative to control cells, in which very littleier Inc.
Figure 5. CD63 Interacts with PMEL CTF
(A) HeLa cells that were mock transfected (left) or transfected with PMEL
expression vector (right) were lysed in buffer containing 1%Brij97, and lysates
were immunoprecipitated with antibodies to CD63, CD81, or PMEL (with
aPmel-C) as indicated. Immunoprecipitates or untreated lysate (Ext) were
analyzed by western blot with aPmel-C (top panels) or anti-CD63 antibody
(bottom panels).
(B) Lysates ofMNT-1 cells that were treated for 24 hr with 1 mMDAPT and lysed
with 1% Brij97 were immunoprecipitated with antibodies to TSPANs CD9,
CD81, CD63 or CD55, to MART-1, or to PMEL using aPmel-C, HMB45, or
HMB50. Immunoprecipitates or untreated lysate (Ext) were fractionated by
reducing (top 2 panels) or nonreducing (bottom two panels) SDS-PAGE and
analyzed by immunoblot with aPmel-C, anti-MART-1, anti-CD63, or
anti-CD81.
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itates, DAPT treatment resulted in a substantial enrichment of
high molecular weight ubiquitin conjugates in immunoprecipi-
tates obtained with aPmel-C but not with antibodies to the
PMEL lumenal domain (Figure 6I). As a control, ubiquitin wasDevelopmassociated with MART-1, a known constitutive substrate for
ubiquitination (Le´vy et al., 2005), regardless of DAPT treatment
(Figure 6I). This indicated that either CTF was itself polyubiquity-
lated or associated with polyubiquitylated proteins. The associ-
ation of CTF with ubiquitin was only observed in MNT-1 cell
lysates prepared with mild detergent (Brij97). When lysates
were prepared with Triton X-100, ubiquitylated proteins did not
coprecipitate with CTF. This suggest either that the CTF associ-
ates with an ubiquitinated partner in a Triton X-100-sensitive
manner or that ubiquinated CTF is only solubilized in mild deter-
gent (data not shown).
In the Absence of CD63, both PMEL Luminal Domain and
CTF Are Sorted and Degraded in an ESCRT-Dependent
Manner
Because PMEL delivery onto ILVs of coated endosomes is
reduced upon CD63 depletion, it was surprising that full-length
PMEL did not accumulate either at the limiting membrane of
coated endosomes (Figure 2C) or in cell lysates (Figure 4B). To
determine the fate of PMEL in CD63-depleted MNT-1 cells we
first quantified the distribution of its luminal domain by IEM. Rela-
tive to control cells, PMEL-luminal domain in CD63-depleted
cells was detected in the Golgi apparatus, vesicular profiles,
and in electron dense membranous organelles with hallmarks
of lysosomes (Figure 7A; illustrated in Figure S5A) that accumu-
late in these cells (Figures 3E and 3F). Interestingly, the PMEL-
luminal domain was detected at similar levels onMVEs of control
and CD63-depleted cells (Figure 7A). As compared to conven-
tional EM (Figures 2B and 2C) IEM does not always allow to
clearly discriminate between coated and noncoated MVEs. To
define MVEs in which PMEL was sorted in absence of CD63
ultrathin cryosections we double immunogold labeled with
HMB50 and an anti-Hrs antibody. In agreement with the conven-
tional EM data showing the presence of ILVs only in noncoated
MVEs (Figure 7B, left), PMEL labeling was observed in MVEs
but not in Hrs-positive endosomes, (Figure 7B, right). In these
MVEs, both PMEL-luminal domain and CTF were associated to
a large degree with the ILVs that are still generated upon CD63
inactivation (Figures 7C and 7D; see also Figure 3F). We interpret
this observation as evidence that full-length PMEL is delivered to
ESCRT-dependent ILVs that continue to form upon CD63 deple-
tion. Consistent with this interpretation, CD63 was not required
for ESCRT-dependent ILV sorting and degradation, because
steady state levels of the melanocyte transmembrane protein,
MART-1—which is known to be ubiquitinated and sorted to
ILVs of MVEs (De Mazie`re et al., 2002; Le´vy et al., 2005)—was
not altered by CD63 depletion (Figure 8E). The lack of effect of
CD63 depletion on ESCRT-dependent ILV formation was not
limited to melanocytic cells, because inactivation of CD63 in
HeLa cells did not affect the ESCRT-dependent sorting and
degradation of the epidermal growth factor receptor (Figures
S5C and S5D).
Our interpretation of these results predicts that CD63 regu-
lates a tight balance between ESCRT-independent and depen-
dent sorting within contiguous membranes of MVEs. Consistent
with this prediction, the bilayered coats on the cytosolic face of
the MVE limiting membrane were unusually expanded in CD63-
depleted cells (Figures 8A and 8B), much like our observations in
DAPT-treated cells (Figure 6G). The increase in coated areasental Cell 21, 708–721, October 18, 2011 ª2011 Elsevier Inc. 715
Figure 6. The PMEL CTF Is Excluded from Melanosomes and Degraded in an ESCRT-I-Dependent Manner
(A) MNT-1 cells treated with control or Tsg101 siRNA were analyzed by western blot using antibodies to b-tubulin, Tsg101, MART-1, or the anti-PMEL antibodies
HMB45 and aPmel-C. Only relevant bands are shown.
(B) MNT-1 cells treated with control or Tsg101 siRNA were analyzed by IFM after labeling for HMB45 (red) and aPmel-C (green). White arrows indicate accu-
mulation of aPmel-C labeling around HMB45 positive spots. Individual labels, a merged image, and a 33magnification of the merged images are shown. Scale
bar represents 10 mm.
(C) Ultrathin cryosections of MNT-1 cells treated with Tsg101 siRNA were immunogold labeled for PMEL cytoplasmic domain with aPmel-C and PAG 15. Scale
bar represents 200 nm.
(D) Ultrathin cryosections of MNT-1 cells treated with Tsg101 siRNA were immunogold labeled for PMEL luminal domain with HMB50 and PAG15 and for PMEL
cytoplasmic domain with aPmel-C and PAG 10, Scale bar represents 200 nm. Examples of MVEs are shown. Whereas the bulk of PMEL luminal domain (black
arrows) is associated with the ILVs (D), the PMEL cytoplasmic domain (empty arrows) is detected at the limiting membrane of the endosome close to, or
associated with the clathrin coat (C) and occasionally associated with the ILVs (D). Scale bar represents 200 nm.
(E–I) MNT-1 cells were treated with DMSO or 1 mM DAPT for 4 hr.
(E) Cells were analyzed by IFM after labeling with HMB50 (red) and aPmel-C (green). Scale bar represents 10 mm.
(F) Ultrathin cryosections were immunogold labeled with HMB50 (PAG 15, arrows) and aPmel-C (PAG10, arrowheads) and analyzed by IEM. After treatment with
DAPT, note the aPmel-C labeling on endo-lysosomal structures and vesicles rather than at the limiting membrane of the PMEL luminal domain-positive
compartment. Scale bar represents 200 nm.
(G) Cells were analyzed by conventional EM. Note the presence of the clathrin coats (black arrowheads) and MVEs (white arrow). Scale bar represents 200 nm.
(H) Ultrathin cryosections were immunogold labeled for aPmel-C (PAG10 indicated by arrowheads). Note the presence of aPmel-C labeling at the limiting
membrane of a clathrin coated MVE. Scale bar represents 200 nm.
(I) MNT-1 cells were treated for 24 hr with DMSO or 1 mM DAPT, and then lysed in buffer containing 1% Brij97. Lysates were immunoprecipitated with anti-
MART-1 or anti-PMEL antibodies aPmel-C, HMB45, or HMB50, and immunoprecipitates or untreated lysate (Ext) were analyzed by immunoblot with an anti-
ubiquitin antibody. Note the enrichment of ubiquitin signal in eluates from aPmel-C antibody immunoprecipitation after DAPT treatment.
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8D) and accumulation of the PMEL luminal domain in coated
regions (Figure 2C). Together, these data suggest that both
PMEL luminal domain and CTF are confined within Hrs enriched
coats for ESCRT-dependent targeting to the endosomal degra-
dative pathway in the absence of CD63.
To test whether PMEL was degraded in an ESCRT-dependent
fashion uponCD63depletion,we assessed thebehavior of PMEL
in cells depleted concomitantly for CD63 and the ESCRT-I
subunit Tsg101. Whereas levels of detergent-soluble Ma, Mb,716 Developmental Cell 21, 708–721, October 18, 2011 ª2011 Elsevand CTF and of total or detergent-insoluble MaC were de-
creased in lysatesof cells treatedwithCD63siRNAalone (Figures
4B and 8E), they were partially or completely restored to control
levels upon concomitant treatment with both siRNAs (Figure 8E).
IEM analyses of cells treated with both siRNAs showed that
most of the ‘‘rescued’’ PMEL lumenal andCTF domains accumu-
lated at the limiting membrane of enlarged vacuolar compart-
ments (Figure 8F). These data support the interpretation that in
the absence of CD63, full-length PMEL becomes a substrate
for ESCRT-dependent sorting and ultimate degradation.ier Inc.
Figure 7. PMEL Luminal Domain Is Targeted to
Uncoated MVE in CD63-Depleted Cells
(A) Quantification of immunogold labeling for PMEL
luminal domain (HMB50) in different compartments on
ultrathin cryosections of MNT-1 cells treated control or
CD63#1 siRNA. Results are expressed as percent-
age (% ± SD) of total immunogold labeling in each
compartments.
(B) Left: MNT-1 cells treated with CD63#1 siRNA were
analyzed by conventional EM. note the presence of MVEs
(arrows) devoid of coats in the vicinity of coated vacuoles
(arrowhead). Scale bar represents 200 nm. Right: ultrathin
cryosections of MNT-1 cells treated with CD63#1 siRNA
were immunogold labeled with HMB50 (PAG 10, arrows)
and Hrs (PAG5, arrowheads) and analyzed by IEM. Note
the HMB50 labeling on endo-lysosomal structures rather
than in Hrs positive compartment. Scale bar represents
200 nm.
(C and D) Ultrathin cryosections of MNT-1 cells treated
with CD63#1 siRNA were immunogold labeled for PMEL
with aPmel-C (PAG 10) and HMB50 (PAG 5) antibodies (C)
or with aPmel-C (PAG 10) and Hrs (PAG 5) antibodies (D)
and analyzed by IEM. The labeling for both PMEL domains
(arrows for aPmel-C and small arrowheads for HMB50) is
detected in degradative MVEs. Scale bar represents
200 nm.
Developmental Cell
Regulation of Endosomal Sorting by CD63DISCUSSION
In this study we show that the TSPAN CD63 is an essential
effector of an ESCRT-independent MVE-generating mechanism
that is ultimately required to initiate polymerization of PMEL
lumenal domains into functional amyloid fibrils. This process
reflects a balance between two sorting events operating on
contiguous endosomal membranes—ESCRT-independent sort-
ing to ILVs and ESCRT-dependent exclusion from these ILVs
of distinct functional domains derived from the single cargo
protein PMEL.
Our data highlight the requirement for the TSPAN CD63 but
not for ceramide in ESCRT-independent ILV generation of
MVEs and for the consequent sorting of PMEL by showing that
(1) PMEL (luminal domain) localizes to CD63-containing ILVs
even in ESCRT-I-depleted cells and that (2) ILV formation,
PMEL sequestration, and downstream melanosome biogenesis
are severely reduced in the absence of CD63 expression but not
of sphingomyelinase expression or activity. This suggests that
distinct ESCRT-independent mechanisms might coexist with
the ESCRT machinery on MVEs in different cells, reflectingDevelopmental Cell 21, 70multipleMVE subpopulations fated for degrada-
tion, exosome secretion, or LRO biogenesis
(Buschow et al., 2009; Hurley et al., 2010;
Simons and Raposo, 2009).
CD63, unlike other TSPANs such as CD9 or
CD81, localizes largely to late endosomes and
lysosomes in different cell types (Pols and
Klumperman, 2009). Our data and other pub-
lished data (Ka¨llquist et al., 2008; Michaux and
Cutler, 2004) show that CD63 in specialized
cells is predominantly associated with LROs
and their endosomal precursors, suggestinga specific role in LRO formation and/or function as proposed
(Pols and Klumperman, 2009). Consistently, whereas lysosomal
defects are not detected in CD63 knockout mice (Schro¨der et al.,
2009), these mice do harbor altered LROs, as shown here for
melanosomes. Although our data indicate that CD63 functions
in melanosomal cargo partitioning in MVEs, given its association
also with mature melanosomes, we cannot exclude that it may
also be involved at later stages of melanogenesis or melano-
some transfer. Furthermore, among TSPANs, CD63 specifically
interacts with LRO cargo partners, such as PMEL (shown here)
and the neutrophil elastase in neutrophils (Ka¨llquist et al.,
2008). Our data predict that other LRO cargoes will be similarly
reliant on CD63 for their partitioning.
Although our previous studies showed that effective PMEL
sorting to ILVs required the luminal domain (Theos et al.,
2006b) and that within MVEs, the luminal domain and CTF
were differentially enriched in ILVs and at the limiting membrane,
respectively (Raposo et al., 2001), we only detected a physical
interaction between CD63 and the PMEL CTF. We propose
that this steady state interaction reflects a transient interaction
between CD63 and full-length PMEL, or with Ma-Mb8–721, October 18, 2011 ª2011 Elsevier Inc. 717
Figure 8. PMEL Luminal Domain Is Degraded in an ESCRT-Dependent Manner in CD63-Depleted Cells
(A) Representative micrographs of coated endosomes. Arrows indicate the characteristic bilayered coats that are expanded upon CD63 inactivation. Scale bar
represents 200 nm.
(B) Shown are the percentage (% ± SD) of coated endosomes relative to the total number of MVEs (left) and the mean length of the coat (right) measured on 50
profiles from each condition. *p < 0.01, xp < 0.05.
(C) Ultrathin cryosections of MNT-1 cells treated with control (left) or CD63#1 siRNA (right) were double immunogold labeled for PMELwith aPmel-C (PAG 10) and
for Hrs (PAG 5) and analyzed by IEM.
(D) For each condition described in c., the number of gold particles associated with aPmel-C and Hrs in coated areas on MVEs was quantified from 50 profiles.
Data are presented as the mean ± SD.
(E) Whole cell lysates of MNT-1 cells treated with control siRNA or CD63#1 siRNA alone or together with siRNA to Tsg101 were analyzed by western blot using
antibodies to CD63, Tsg101, MART-1, b-tubulin, or anti-PMEL antibodies aPmel-C, HMB45, or aPmel-N. Relevant bands are indicated.
(F) Ultrathin cryosections of MNT-1 cells treated with CD63 and Tsg101 siRNA were immunogold labeled with aPmel-C (PAG 10, arrowheads) and HMB50
(PAG5, arrows) and analyzed by IEM. Note that both labeling are broadly localized to the limiting membrane. Scale bar represents 200 nm.
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These data, together with the impact of CD63 depletion on
PMEL sorting and downstream amyloidogenic processing,
support a model in which the interaction of CD63 with the
PMEL CTF stabilizes PMEL within endosomal domains that
are rapidly targeted for ESCRT-independent ILV formation.
This interaction is likely to be short-lived, with rapid proteolytic
release of CTF from Ma and incorporation of Ma onto forming
ILVs. This interpretation is consistent with the rapid proteolytic
maturation of PMEL in post-Golgi compartments (Berson
et al., 2003) and the steady-state enrichment of PMEL lumenal
domains within endosomes on ILVs (Berson et al., 2001, 2003;
Raposo et al., 2001). Alternatively, the CTF region and luminal
domain of PMEL might independently contribute to ESCRT-
independent/CD63-dependent ILV sorting. This model would
be consistent with the concomitant detection of CD63 and
both the lumenal and cytoplasmic domains of PMEL in ILVs in
HeLa cells (Berson et al., 2001, 2003), and with the smaller ILV
size and incomplete amyloidogenesis associatedwith a chimeric
construct lacking the PMEL cytoplasmic domain (Theos et al.,
2006b).
Remarkably, although the CTF appears to facilitate ESCRT-
independent sorting by diverting PMEL from the ESCRT
machinery, its own fate is to be degraded in an ESCRT-depen-
dent manner. The association of the CTF with ubiquitylated
proteins suggests that the CTF might be a passive passenger
of the ESCRT pathway. Exactly how the CTF is sorted for degra-
dation is not clear. It is possible that CTF accompanies PMEL
luminal domains during invagination onto ILVs, and then
becomes reexposed on the endosomal limiting membrane
upon back fusion of the ILVs; a similar process has been pro-
posed in other cell systems (Falguie`res et al., 2008; van Nispen
tot Pannerden et al., 2010), and would be consistent with our
electron tomography analyses of early melanosomes/MVEs
(Hurbain et al., 2008). Alternatively, the CTF could be retained
on the MVE membrane after PMEL cleavage and segregation
from the luminal domain, which—perhaps by virtue of an affinity
for ILV-enriched components—would associate with CD63-
dependent ILVs. Either mechanism would expose the isolated
CTF, either directly or indirectly in association with an ubiquity-
lated partner, to ESCRT-containing clathrin coats on the MVE
limiting membrane (Raposo et al., 2001; Theos et al., 2006b;
Truschel et al., 2009). ESCRT-dependent sorting is likely to be
tightly linked to cleavage of the CTF by the g-secretase, which
is required for CTF disposal (this study and Kummer et al.,
2009). The reported localization and activity of g-secretase to
the limiting membrane of lysosomes (Pasternak et al., 2003)
could reconcile both events. Confirmation of this hypothesis
requires further investigations.
Our data have important implications for distinct fates of ILVs
that are formed by different mechanisms. We show that whereas
the CD63-dependent ILVs bearing PMEL luminal domains are
ultimately destined for melanosomes, the CD63-independent,
ESCRT-dependent vesicles bearing CTF are destined for degra-
dation. The formation of ESCRT-independent ILVs and the
sequestration of PMEL CTF in ESCRT-dependent clathrin coats
on the cytosolic side of the same endosomal membrane suggest
that distinct but concomitant sorting mechanisms are integrated
within a single compartment (Buschow et al., 2009; Simons andDevelopmRaposo, 2009). We propose that a key role for the CD63-
dependent pathway is to protect cargoes from ESCRT-
dependent degradation. This is supported by the lack of effect
of CD63 inactivation on ESCRT-dependent cargoes (EGFR)
and by the confinement of ESCRT-independent cargoes (PMEL
luminal domain) to clathrin and Hrs-positive coats for sub-
sequent ESCRT-dependent degradation in absence of CD63
(Figure 2C and Figure 8). Whether degradative MVEs mature
from clathrin-coated subdomains or are distinct compartments
will require further study.
Finally, we show that the loss of ESCRT-independent PMEL
sorting in CD63-depleted cells is accompanied by a decrease
of PMEL amyloid formation. This is consistent with a model in
which MVEs provide an environment conducive for the proteo-
lytic processing and unfolding of amyloidogenic precursors,
supported by our previous observations by high resolution by
electron tomography (Hurbain et al., 2008) and studies by others
(Kova´cs et al., 2007). The link between ILV formation, the TSPAN
CD63 and the generation of physiological PMEL amyloid opens
a new avenue for further understanding the mechanisms under-
lying the formation of amyloid in pathological models.EXPERIMENTAL PROCEDURES
Cell Culture, Drug and EGF Treatment, Transfection, and siRNA
Depletion
HumanmelanocyticMNT-1 cells andHeLa cells weremaintained as previously
described (Berson et al., 2001; Raposo et al., 2001). Cells were treated for 24 hr
with 1 mM DAPT (Sigma), 2.5 mM GW4869 (Sigma), or a cocktail of lysosomal
proteases inhibitors Leupeptin, Ca-074Me, and pepstatin A (10 mg/ml) (Sigma).
For EGF pulse chase, cells were starved for 4 hr in serum free cell culture
medium and pulsed with EGF-biotin at 50 ng/ml (Invitrogen) for 30 min at
37C. Cells were then washed and chased at 37C with serum free cell culture
medium. HeLa cells were transfected with plasmid constructs using Lipofect-
amine 2000 (Invitrogen) following the manufacturer’s recommendations and
cells were collected and analyzed 48 hr after transfection. MNT-1 cells were
transduced with siRNA duplex oligonucleotides (listed in the Supplemental
Experimental Procedures) as reported (Theos et al., 2006b). Cells were sub-
jected to one round of siRNA transduction and processed at day 3.
Western Blot
MNT-1 cells at 80% confluency were washed in cold PBS and lysed on ice in
lysis buffer (50 mM Tris, 150 mM NaCl, 0.1% (v/v) Triton X-100, 10 mM EDTA,
pH 7.2, 10 mMN-ethylmaleimide [Sigma]), 5 mM oxidized glutathione (Calbio-
chem), and protease inhibitor cocktail (Roche). Triton X-100 insoluble material
was obtained as previously described (Berson et al., 2001). Lysates were incu-
bated in sample buffer with or without 350 mM 2-mercapthethanol (Sigma),
boiled for 5 min, and fractionated by SDS-PAGE using Nupage (3%–8%)
Tris-acetate gels (Invitrogen) or Nupage (4%–12%) Bis-Tris gels (Invitrogen)
and transferred onto nitrocellulose membranes (Millipore). The membranes
were blocked in PBS/0.1%Tween-20 (PBS/T) with 5% nonfat dried milk, incu-
bated with indicated primary antibody (listed in the Supplemental Experi-
mental Procedures) diluted in PBS/T, washed four times in blocking solution,
and finally incubated with HRP-conjugated secondary antibody followed by
washing in PBS/T. Blots were developed using the ECL Plus western blotting
detection system (GE Healthcare) according to the manufacturer’s instruction.
Signal intensities were quantified with Image J software.
For immunoprecipitation and corresponding western blot, cells were lysed
directly in lysis buffer (30 mM Tris, pH 7.4, 150 mM NaCl, 1 mM CaCl2,
1 mM MgCl2, and 0.02% NaN3) containing 1% (w/v) Brij97 (Sigma) and prote-
ases inhibitors. After 30 min at 4C, insoluble material was removed by centri-
fugation at 12,000 3 g and cell lysate was precleared for 2 hr by addition of
1/1000 volume heat inactivated goat serum and 20 ml protein G-Sepharose
beads (Amersham Bioscience). Proteins were then immunoprecipitated byental Cell 21, 708–721, October 18, 2011 ª2011 Elsevier Inc. 719
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400 ml lysate. After 2 hr incubation at 4C under constant agitation, beads
were washed five times in lysis buffer containing 1% Brij97. The immunopre-
cipitates were fractionated by 5%–15% SDS-PAGE under nonreducing or
reducing conditions and transferred to a nitrocellulose membrane (Amersham
Bioscience). Membranes were probed as described above, except for Biotin-
labeled primary antibodies (anti-CD63; anti-CD81) where AlexaFluor 680-
streptavidin conjugates or Alexa Fluor 800-streptavidin conjugates (Invitrogen)
were used for detection and blots were developed using the Odyssey Infrared
Imaging System (LI-COR Biosciences).
Immunofluorescence Microscopy
Untreated, drug-treated, or transfected MNT-1 cells on coverslips were rinsed
in PBS and fixed for 15min in 4%paraformaldehyde/PBS at room temperature
(RT). Fixed cells were washed in PBS and quenched 10 min in PBS/50 mM
glycine, saturated in PBS containing 1 mg/ml BSA (blocking buffer), and per-
meabilized in PBS/0.05% saponin/1 mg/ml BSA (incubation buffer, IB). Cells
were incubated 1 hr with the primary antibody (listed in the Supplemental
Experimental Procedures) diluted in IB, washed three times in IB, and incu-
bated with the corresponding secondary anti-rabbit and anti-mouse anti-
bodies conjugated to Alexa 488 or Alexa 568 (Molecular Probes/ Invitrogen)
diluted in IB for 45 min. Coverslips were washed three times with IB and
thenmounted in DABCOmedium and examined on a LeicaMicrosystem (Nan-
terre, France) DM-RXA2 3D deconvolution microscope equipped with a piezo
z-drive (Physik Instrument, Pantin, France) and a 1003 1.4 NA PL-APO objec-
tive lens. Images are maximum-intensity z projections of 3D image stacks
(except Figure 6B, which shows a single deconvolved layer) acquired every
0.2 mm using Metamorph software (MDS Analytical Technologies, Sunnyvale,
CA) and a Coolsnap HQ (Photometrics Coolsnap HQ) cooled CCD-camera.
Electron Microscopy
For conventional EM of MNT-1 cells, cells grown on coverslips were fixed with
2.5% glutaraldehyde in 0.1 M cacodylate buffer for 24 hr and processed for
Epon embedding as described (Raposo et al., 2001). For EM analysis of
RPE sections, tissues from two CD63/ mice (aged 2 months) and two
age-matched wild-type mice were fixed by perfusion of the mice with glutaral-
dehyde (6% in PBS). Tissue blocks from the eyes were processed for Epon
embedding and ultrathin sections were contrasted with uranyl acetate and
lead citrate as described (Lopes et al., 2007). For ultrathin cryosectioning
and immunogold labeling, cells were fixed with 2% PFA or with a mixture of
2% PFA and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. Cells
were processed for ultracryomicrotomy and single or double immunogold
labeled using PAG10 or PAG15 as reported (Raposo et al., 2001). All samples
were analyzed using a FEI CM120 electron microscope (FEI Company), and
digital acquisitions were made with a numeric camera (Keen View; Soft
Imaging System, SIS, Germany).
Image Analysis and Quantification
Quantification of immunogold labeling on ultrathin cryosections was per-
formed as described previously (Delevoye et al., 2009). Melanin content was
performed as described (Wasmeier et al., 2006). The relative distribution of
PMEL luminal and CD63 in MNT-1 cells was evaluated by direct EM analysis
of randomly selected cell profiles from two distinct grids. More than 1500
gold particles for each condition were counted and assigned to the compart-
ment over which they were located. For quantification of distinct compart-
ments in siRNA-treated cells and controls, each of the compartments was
defined by its morphology and by correlation with immunogold labeling for
different organelle-markers (EEA1 and Hrs for early endosomes, TGN46 for
the TGN, LAMP-1 for late endosomes/lysosomes) and internalized endocytic
tracers (BSA-gold and Tf-FITC for endosomes of different maturation stage)
as previously described (Raposo et al., 2001). MVBs or MVEs were defined
as compartments delimited by a membrane with numerous internal vesicles;
coated MVEs have few internal vesicles and an electron dense coat on at least
one face of the limiting membrane. Electron-dense compartments with no or
few internal membranes were classified as lysosomes. Melanosome stages
were defined by morphology (Raposo et al., 2001; Seiji et al., 1963). Quantifi-
cation of PMEL luminal domain distribution in MVEs of MNT-1 cells was per-
formed on single immunogold labeled cryosections by counting the number720 Developmental Cell 21, 708–721, October 18, 2011 ª2011 Elsevof gold particles on the limiting membrane and on ILVs. Labeling was consid-
ered to be associated with the limiting membrane when the gold particle was
within 20 nm of the limiting membrane and with no cross-sectioned ILVs in the
direct vicinity. Results are presented as a percentage of the total number of
gold particles on ILVs in each compartment and represent a mean and stan-
dard deviation of three independent experiments. Quantification of average
diameter of MVEs and the length of clathrin coat was determined using the
iTEM software (Soft Imaging System).SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.devcel.2011.08.019.ACKNOWLEDGMENTS
We are grateful to D. Tenza, I. Hurbain, C. Delevoye, S. Held, B. Watt, and R.
Lu¨llmann-Rauch for technical help, insightful discussions during the course of
this work, and critical reading of the manuscript. We are grateful to V. Fraisier
and L. Sengmanivong (Nikon Imaging Center, PITC-IBiSA Imaging Facility, In-
stitut Curie) for assistancewith deconvolutionmicroscopy. This work was sup-
ported by Institut Curie, CNRS, Agence National de la Recherche, Fondation
pour la Recherche Medicale, and Association pour la Recherche sur le Cancer
(to G.R.), the Deutsche Forschungsgemeinschaft GRK1459 (to P.S.), and NIH
grant R01 AR048155 (to M.S.M.).
Received: December 21, 2010
Revised: June 10, 2011
Accepted: August 23, 2011
Published online: September 29, 2011
REFERENCES
Berson, J.F., Harper, D.C., Tenza, D., Raposo, G., and Marks, M.S. (2001).
Pmel17 initiates premelanosomemorphogenesis within multivesicular bodies.
Mol. Biol. Cell 12, 3451–3464.
Berson, J.F., Theos, A.C., Harper, D.C., Tenza, D., Raposo, G., and Marks,
M.S. (2003). Proprotein convertase cleavage liberates a fibrillogenic fragment
of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol. 161,
521–533.
Buschow, S.I., Nolte-’t Hoen, E.N., van Niel, G., Pols, M.S., ten Broeke, T.,
Lauwen, M., Ossendorp, F., Melief, C.J., Raposo, G., Wubbolts, R., et al.
(2009). MHC II in dendritic cells is targeted to lysosomes or T cell-induced
exosomes via distinct multivesicular body pathways. Traffic 10, 1528–1542.
Charrin, S., le Naour, F., Silvie, O., Milhiet, P.E., Boucheix, C., and Rubinstein,
E. (2009). Lateral organization of membrane proteins: tetraspanins spin their
web. Biochem. J. 420, 133–154.
de Gassart, A., Geminard, C., Fevrier, B., Raposo, G., and Vidal, M. (2003).
Lipid raft-associated protein sorting in exosomes. Blood 102, 4336–4344.
De Mazie`re, A.M., Muehlethaler, K., van Donselaar, E., Salvi, S., Davoust, J.,
Cerottini, J.C., Le´vy, F., Slot, J.W., and Rimoldi, D. (2002). The melanocytic
protein Melan-A/MART-1 has a subcellular localization distinct from typical
melanosomal proteins. Traffic 3, 678–693.
Delevoye, C., Hurbain, I., Tenza, D., Sibarita, J.B., Uzan-Gafsou, S., Ohno, H.,
Geerts, W.J., Verkleij, A.J., Salamero, J., Marks, M.S., and Raposo, G. (2009).
AP-1 and KIF13A coordinate endosomal sorting and positioning during
melanosome biogenesis. J. Cell Biol. 187, 247–264.
Falguie`res, T., Luyet, P.P., Bissig, C., Scott, C.C., Velluz, M.C., andGruenberg,
J. (2008). In vitro budding of intralumenal vesicles into late endosomes is
regulated by Alix and Tsg101. Mol. Biol. Cell 19, 4942–4955.
Fang, Y., Wu, N., Gan, X., Yan, W., Morrell, J.C., and Gould, S.J. (2007).
Higher-order oligomerization targets plasma membrane proteins and HIV
gag to exosomes. PLoS Biol. 5, e158.ier Inc.
Developmental Cell
Regulation of Endosomal Sorting by CD63Fowler, D.M., Koulov, A.V., Alory-Jost, C., Marks, M.S., Balch, W.E., and Kelly,
J.W. (2006). Functional amyloid formation within mammalian tissue. PLoS Biol.
4, e6.
Gruenberg, J., and Stenmark, H. (2004). The biogenesis of multivesicular
endosomes. Nat. Rev. Mol. Cell Biol. 5, 317–323.
Harper, D.C., Theos, A.C., Herman, K.E., Tenza, D., Raposo, G., and Marks,
M.S. (2008). Premelanosome amyloid-like fibrils are composed of only golgi-
processed forms of Pmel17 that have been proteolytically processed in endo-
somes. J. Biol. Chem. 283, 2307–2322.
Hoashi, T., Watabe, H., Muller, J., Yamaguchi, Y., Vieira, W.D., and Hearing,
V.J. (2005). MART-1 is required for the function of the melanosomal matrix
protein PMEL17/GP100 and the maturation of melanosomes. J. Biol. Chem.
280, 14006–14016.
Hoashi, T., Muller, J., Vieira, W.D., Rouzaud, F., Kikuchi, K., Tamaki, K., and
Hearing, V.J. (2006). The repeat domain of the melanosomal matrix protein
PMEL17/GP100 is required for the formation of organellar fibers. J. Biol.
Chem. 281, 21198–21208.
Hurbain, I., Geerts,W.J., Boudier, T., Marco, S., Verkleij, A.J., Marks,M.S., and
Raposo, G. (2008). Electron tomography of early melanosomes: implications
for melanogenesis and the generation of fibrillar amyloid sheets. Proc. Natl.
Acad. Sci. USA 105, 19726–19731.
Hurley, J.H. (2008). ESCRT complexes and the biogenesis of multivesicular
bodies. Curr. Opin. Cell Biol. 20, 4–11.
Hurley, J.H., Boura, E., Carlson, L.A., and Ro´ _zycki, B. (2010). Membrane
budding. Cell 143, 875–887.
Ka¨llquist, L., Hansson, M., Persson, A.M., Janssen, H., Calafat, J., Tapper, H.,
and Olsson, I. (2008). The tetraspanin CD63 is involved in granule targeting of
neutrophil elastase. Blood 112, 3444–3454.
Kova´cs, G.G., Gelpi, E., Stro¨bel, T., Ricken, G., Nyengaard, J.R., Bernheimer,
H., and Budka, H. (2007). Involvement of the endosomal-lysosomal system
correlates with regional pathology in Creutzfeldt-Jakob disease.
J. Neuropathol. Exp. Neurol. 66, 628–636.
Kummer, M.P., Maruyama, H., Huelsmann, C., Baches, S., Weggen, S., and
Koo, E.H. (2009). Formation of Pmel17 amyloid is regulated by juxtamembrane
metalloproteinase cleavage, and the resulting C-terminal fragment is
a substrate for gamma-secretase. J. Biol. Chem. 284, 2296–2306.
Kushimoto, T., Basrur, V., Valencia, J., Matsunaga, J., Vieira, W.D., Ferrans,
V.J., Muller, J., Appella, E., and Hearing, V.J. (2001). A model for melanosome
biogenesis based on the purification and analysis of early melanosomes. Proc.
Natl. Acad. Sci. USA 98, 10698–10703.
Le´vy, F., Muehlethaler, K., Salvi, S., Peitrequin, A.L., Lindholm, C.K., Cerottini,
J.C., and Rimoldi, D. (2005). Ubiquitylation of a melanosomal protein by
HECT-E3 ligases serves as sorting signal for lysosomal degradation. Mol.
Biol. Cell 16, 1777–1787.
Lopes, V.S., Wasmeier, C., Seabra, M.C., and Futter, C.E. (2007). Melanosome
maturation defect in Rab38-deficient retinal pigment epithelium results in
instability of immature melanosomes during transient melanogenesis. Mol.
Biol. Cell 18, 3914–3927.
Michaux, G., and Cutler, D.F. (2004). How to roll an endothelial cigar: the
biogenesis of Weibel-Palade bodies. Traffic 5, 69–78.
Pasternak, S.H., Bagshaw, R.D., Guiral, M., Zhang, S., Ackerley, C.A., Pak,
B.J., Callahan, J.W., and Mahuran, D.J. (2003). Presenilin-1, nicastrin, amyloid
precursor protein, and gamma-secretase activity are co-localized in the lyso-
somal membrane. J. Biol. Chem. 278, 26687–26694.
Pols, M.S., and Klumperman, J. (2009). Trafficking and function of the
tetraspanin CD63. Exp. Cell Res. 315, 1584–1592.
Raiborg, C., and Stenmark, H. (2009). The ESCRT machinery in endosomal
sorting of ubiquitylated membrane proteins. Nature 458, 445–452.
Raiborg, C., Wesche, J., Malerød, L., and Stenmark, H. (2006). Flat clathrin
coats on endosomes mediate degradative protein sorting by scaffolding Hrs
in dynamic microdomains. J. Cell Sci. 119, 2414–2424.DevelopmRaiborg, C., Malerød, L., Pedersen, N.M., and Stenmark, H. (2008). Differential
functions of Hrs and ESCRT proteins in endocytic membrane trafficking. Exp.
Cell Res. 314, 801–813.
Raposo, G., and Marks, M.S. (2007). Melanosomes—dark organelles
enlighten endosomal membrane transport. Nat. Rev. Mol. Cell Biol. 8,
786–797.
Raposo, G., Tenza, D., Murphy, D.M., Berson, J.F., and Marks, M.S. (2001).
Distinct protein sorting and localization to premelanosomes, melanosomes,
and lysosomes in pigmented melanocytic cells. J. Cell Biol. 152, 809–824.
Raposo, G., Marks, M.S., and Cutler, D.F. (2007). Lysosome-related organ-
elles: driving post-Golgi compartments into specialisation. Curr. Opin. Cell
Biol. 19, 394–401.
Sachse, M., Urbe´, S., Oorschot, V., Strous, G.J., and Klumperman, J. (2002).
Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting
toward lysosomes. Mol. Biol. Cell 13, 1313–1328.
Schro¨der, J., Lu¨llmann-Rauch, R., Himmerkus, N., Pleines, I., Nieswandt, B.,
Orinska, Z., Koch-Nolte, F., Schro¨der, B., Bleich, M., and Saftig, P. (2009).
Deficiency of the tetraspanin CD63 associated with kidney pathology but
normal lysosomal function. Mol. Cell. Biol. 29, 1083–1094.
Seiji, M., Shimao, K., Birbeck, M.S., and Fitzpatrick, T.B. (1963). Subcellular
localization of melanin biosynthesis. Ann. N Y Acad. Sci. 100, 497–533.
Simons, M., and Raposo, G. (2009). Exosomes—vesicular carriers for intercel-
lular communication. Curr. Opin. Cell Biol. 21, 575–581.
Stuffers, S., Sem Wegner, C., Stenmark, H., and Brech, A. (2009).
Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10,
925–937.
Theos, A.C., Truschel, S.T., Raposo, G., and Marks, M.S. (2005). The Silver
locus product Pmel17/gp100/Silv/ME20: controversial in name and in func-
tion. Pigment Cell Res. 18, 322–336.
Theos, A.C., Berson, J.F., Theos, S.C., Herman, K.E., Harper, D.C., Tenza, D.,
Sviderskaya, E.V., Lamoreux, M.L., Bennett, D.C., Raposo, G., and Marks,
M.S. (2006a). Dual loss of ER export and endocytic signals with altered mela-
nosome morphology in the silver mutation of Pmel17. Mol. Biol. Cell 17, 3598–
3612.
Theos, A.C., Truschel, S.T., Tenza, D., Hurbain, I., Harper, D.C., Berson, J.F.,
Thomas, P.C., Raposo, G., and Marks, M.S. (2006b). A lumenal domain-
dependent pathway for sorting to intralumenal vesicles of multivesicular
endosomes involved in organelle morphogenesis. Dev. Cell 10, 343–354.
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F.,
Schwille, P., Bru¨gger, B., and Simons, M. (2008). Ceramide triggers budding
of exosome vesicles into multivesicular endosomes. Science 319, 1244–1247.
Truschel, S.T., Simoes, S., Setty, S.R., Harper, D.C., Tenza, D., Thomas, P.C.,
Herman, K.E., Sackett, S.D., Cowan, D.C., Theos, A.C., et al. (2009). ESCRT-I
function is required for Tyrp1 transport from early endosomes to the melano-
some limiting membrane. Traffic 10, 1318–1336.
van Niel, G., Porto-Carreiro, I., Simoes, S., and Raposo, G. (2006). Exosomes:
a common pathway for a specialized function. J. Biochem. 140, 13–21.
van Nispen tot Pannerden, H.E., Geerts, W.J., Kleijmeer, M.J., and Heijnen,
H.F. (2010). Spatial organization of the transforming MHC class II compart-
ment. Biol. Cell 102, 581–591.
Vidal, M., Mangeat, P., and Hoekstra, D. (1997). Aggregation reroutes mole-
cules from a recycling to a vesicle-mediated secretion pathway during reticu-
locyte maturation. J. Cell Sci. 110, 1867–1877.
Wasmeier, C., Romao, M., Plowright, L., Bennett, D.C., Raposo, G., and
Seabra, M.C. (2006). Rab38 and Rab32 control post-Golgi trafficking of mela-
nogenic enzymes. J. Cell Biol. 175, 271–281.
Watt, B., van Niel, G., Fowler, D.M., Hurbain, I., Luk, K.C., Stayrook, S.E.,
Lemmon, M.A., Raposo, G., Shorter, J., Kelly, J.W., and Marks, M.S. (2009).
N-terminal domains elicit formation of functional Pmel17 amyloid fibrils.
J. Biol. Chem. 284, 35543–35555.ental Cell 21, 708–721, October 18, 2011 ª2011 Elsevier Inc. 721
